June 10, 2020 / 8:55 AM / a month ago

Singapore approves Gilead's remdesivir for COVID-19 treatment

SINGAPORE, June 10 (Reuters) - Singapore’s Health Sciences Authority said on Wednesday it granted conditional approval for Gilead Sciences Inc’s antiviral drug remdesivir for the treatment of some patients with COVID-19 infection.

South Korea, Japan, India and the United States have also approved the drug for emergency use. (Reporting by Aradhana Aravindan and John Geddie in Singapore, editing by Louise Heavens)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below